Vet360 Issue 2 Volume 3 | Page 33

NEW
NEW

IDEXX SDMA
A revolutionary medical
breakthrough
in kidney diagnostics
After nearly a decade of research and development, IDEXX is proud to introduce the first and
only veterinary specific SDMA test.
The new IDEXX SDMA (symmetric dimethylarginine) assay enables the identification of
chronic kidney disease (CKD) in cats and

dogs substantially earlier than traditional
tests.
Identify kidney disease sooner, intervene
earlier and find the best approach for each
animal. Available only from IDEXX Reference
Laboratories.

Experience the Benefits of Early Detection

25%
In time, kidney disease
will develop in:
1 in 10 dogs and 1 in 3 cats

As little as 25 % of kidney
function remaining at time of
diagnosis with CREA

60%
Up to 60 % of kidney
function remaining at time
of diagnosis with SDMA

For more information visit:
idexxsdma.com
Reference
1. Hand MS, Thatcher CD, Remillard RL, et al., eds. Small Animal Clinical Nutrition. 5th ed. Topeka, KS: Mark Morris Institute; 2010.
2. Grauer GF. Staging and management of canine chronic kidney disease. dvm360. 2009.
http://veterinarynews.dvm360.com/staging-and-management-canine-chronic-kidney-disease.
3. Hall JA, Yerramilli M, Obare E, et al. Comparison of serum concentrations of symmetric
dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J Vet Intern Med. 2014;28(6):1676-1683.
© 2015 IDEXX Laboratories, Inc. All rights reserved. • 1509012-0915-EU All ®/TM marks are owned by IDEXX Laboratories,
Inc. or its affiliates in the United States and/or other countries. The IDEXX Privacy Policy is available at idexx.com.

April 2016 Vet360 for Madaleen Review.indd 33

2016/03/24 2:24 PM